Financials California Nanotechnologies Corp. OTC Markets

Equities

CANOF

CA1304921010

Industrial Machinery & Equipment

Delayed OTC Markets 11:07:45 10/05/2024 pm IST 5-day change 1st Jan Change
0.3091 USD +1.41% Intraday chart for California Nanotechnologies Corp. +17.48% +86.54%

Valuation

Fiscal Period: February 2018 2019 2020 2021 2022 2023
Capitalization 1 1.722 1.432 1.055 3.821 1.985 3.029
Enterprise Value (EV) 1 3.533 3.17 2.731 5.336 3.631 4.238
P/E ratio -36.4 x -24.2 x -18.8 x -31.6 x 9.82 x 39.2 x
Yield - - - - - -
Capitalization / Revenue 3.14 x 1.91 x 1.27 x 4.81 x 1.84 x 2.19 x
EV / Revenue 6.44 x 4.23 x 3.29 x 6.72 x 3.36 x 3.07 x
EV / EBITDA -1,339 x 22.9 x 19.3 x 661 x 11.2 x 13.9 x
EV / FCF -6.13 x 32.9 x 21.9 x 56.1 x 536 x 10.5 x
FCF Yield -16.3% 3.04% 4.57% 1.78% 0.19% 9.57%
Price to Book -1.53 x -1.22 x -0.88 x -2.92 x -1.85 x -3.2 x
Nbr of stocks (in thousands) 31,430 31,430 31,430 31,430 31,804 31,804
Reference price 2 0.0548 0.0455 0.0336 0.1216 0.0624 0.0953
Announcement Date 28/06/18 28/06/19 29/06/20 28/06/21 28/06/22 28/06/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: February 2018 2019 2020 2021 2022 2023
Net sales 1 0.5486 0.7498 0.8311 0.7946 1.082 1.382
EBITDA 1 -0.002639 0.1384 0.1411 0.008073 0.3228 0.3038
EBIT 1 -0.0668 0.0124 0.013 -0.1218 0.21 0.1893
Operating Margin -12.17% 1.65% 1.56% -15.33% 19.42% 13.7%
Earnings before Tax (EBT) 1 -0.0465 -0.0584 -0.0585 -0.121 0.2006 0.0838
Net income 1 -0.0473 -0.0592 -0.0561 -0.121 0.2006 0.0798
Net margin -8.62% -7.89% -6.75% -15.22% 18.55% 5.77%
EPS 2 -0.001505 -0.001882 -0.001784 -0.003848 0.006357 0.002433
Free Cash Flow 1 -0.5765 0.0964 0.1248 0.0952 0.006773 0.4055
FCF margin -105.1% 12.86% 15.01% 11.98% 0.63% 29.35%
FCF Conversion (EBITDA) - 69.67% 88.42% 1,178.64% 2.1% 133.47%
FCF Conversion (Net income) - - - - 3.38% 508.42%
Dividend per Share - - - - - -
Announcement Date 28/06/18 28/06/19 29/06/20 28/06/21 28/06/22 28/06/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: February 2018 2019 2020 2021 2022 2023
Net Debt 1 1.81 1.74 1.68 1.51 1.65 1.21
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -686.3 x 12.56 x 11.87 x 187.6 x 5.098 x 3.978 x
Free Cash Flow 1 -0.58 0.1 0.12 0.1 0.01 0.41
ROE (net income / shareholders' equity) 4.23% 5.15% 4.73% 9.65% -16.8% -7.9%
ROA (Net income/ Total Assets) -7.15% 0.92% 1.14% -13.7% 18.4% 11.9%
Assets 1 0.662 -6.402 -4.901 0.8804 1.088 0.6729
Book Value Per Share 2 -0.0400 -0.0400 -0.0400 -0.0400 -0.0300 -0.0300
Cash Flow per Share 2 0 0 0 0 0 0.0100
Capex 1 0.65 0.02 - - 0.01 0.09
Capex / Sales 118.6% 2.73% - - 0.71% 6.21%
Announcement Date 28/06/18 28/06/19 29/06/20 28/06/21 28/06/22 28/06/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. CNO Stock
  4. CANOF Stock
  5. Financials California Nanotechnologies Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW